Emma Rushbrooke MPhil (Audiology), BA, DipAud, MAudSA, LSLS Cert AVT, RNC
Clinical Director, Hear and Say
AG Bell Academy Chairperson

Emma is an Audiologist and LSLS Certified Auditory-Verbal Therapist, currently Clinical Director of Hear and Say, an Early Intervention program for children with hearing loss. Over 20 years’ experience working with children with hearing loss, specialising in implantable hearing technology and Auditory-Verbal Therapy. Research interests include telehealth, unilateral hearing loss and implantable technologies. Emma completed a Master of Philosophy in 2012 at the University of Queensland, researching the validity of remote mapping in children and she also co-edited the 2016 book “Telepractice in Audiology” and is the co-author of Chapter 25 “Telepractice and Auditory-Verbal Therapy” in the 2020 book Auditory-Verbal Therapy: Science, Research and Practice. Emma is the current Chair of the AG Bell Academy Board and is also involved in training and mentoring both nationally and internationally.

Major themes/areas of research
Emma has extensive research experience, her research interests including telehealth, unilateral hearing loss, listening effort, and implantable technologies. Emma’s research has been particularly
important in providing innovative tele-audiological solutions for people living in regional and remote areas. Emma’s Master of Philosophy dissertation (The University of Queensland, 2012) entitled Remote MAPping for Children with Cochlear Implants was the first study to examine the validity of telemapping and since that time, she has been instrumental in furthering hearing-related telehealth research including remote speech perception testing.